Is XGEVA FDA approved?
Is XGEVA FDA approved? Amgen Inc. (Nasdaq: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved XGEVA(TM) (denosumab), the first and only RANK Ligand inhibitorfor the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors. When was XGEVA approved by FDA? Development Timeline for XgevaDateArticleJun 13, 2013Approval FDA Approves Xgeva to Treat Giant Cell Tumor of the BoneNov 19, 2010Approval FDA Approves Amgen's Xgeva (denosumab) for the Prevention of Skeletal-Related Events in Patients with Bone Metastases from Solid Tumors Are orphan drugs FDA approved? The FDA has authority to grant orphan-drug designation...